|
CERO CERo Therapeutics Holdings Inc 1870404 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,028,830.00 |
| Balance Sheet |
|
Current Assets
|
$1,547,950.00 |
|
Assets
|
$1,899,971.00 |
|
Current Liabilities
|
$32,405,268.00 |
|
Liabilities
|
$32,405,268.00 |
|
Equity
|
$-30,505,297.00 |
|
Shares Out
|
5845.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-5,088,959.00 |
|
Investing Cash Flow
|
$-7,944,740.00 |
| Market Analysis |
Market Cap
|
$58.45 |
|
Price
|
$0.01 |
|
PB
|
0.20 |
|
EPS
|
-0.70 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:33:06 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:55 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CERO documents filed with the SEC.
CERO Filings
Clear
